Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies. METHODS: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B12 and B6. RESULTS: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled. CONCLUSIONS: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adjudication for Alzheimer’s phenotypes was done by a committee41, comprising at least two neurologists and a neuropsychologist.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [41]
In the citing paper
“Dementia diagnoses were made according to DSM‐IV criteria, based on longitudinal cognitive assessments, caregiver interviews, medical records, neuroimaging, and autopsy data when available.”
From Blood PCSK9 Impacts Alzheimer's Disease Risk in an APOE Genotype‐Dependent Manner: A Prospective Cohort Study (2026) · cites this paper as [18]
In the citing paper
“Overall, of the 19 selected cohort studies linking Hcy to the various cognitive outcomes, 12(63.2%) found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest [206,215,217,219,222-224,228,231,233-235]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [206]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Research works printed but not linked: 3
- Berg L, 1988, Psychopharmacol Bull, 24, 637
- Levin ML, 1953, Acta Unio Int Contr Cancrum, 9, 531
- 1996, Fed Regist, 61, 8781
Cited by
Items 801–900 of 1,022
Preventive effects of Chlorella on cognitive decline in age-dependent dementia model mice
Nakashima, Y., Ohsawa, I., Konishi, F., Hasegawa, T., Kumamoto, S., Suzuki, Y., & Ohta, S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.044 · Cited by 70
Verhoef, P., Steenge, G. R., Boelsma, E., van Vliet, T., Olthof, M. R., & Katan, M. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.674 · Cited by 72
Dittmann, S., Seemüller, F., Schwarz, M., Kleindienst, N., Stampfer, R., Zach, J., Born, C., Bernhard, B., Fast, K., Grunze, H., et al. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00412.x · Cited by 65
The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia—Review
Dymara-Konopka, W., & Laskowska, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112757 · Cited by 76
Annerbo, S., Wahlund, L.-O., & Lökk, J. (2006) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317506289282 · Cited by 65
“The elevated levels of homocysteine are suggested to be predictive of AD conversion, a finding in line with other studies.(7,9) In our study, it seems like that the predictive value of homocysteine levels decreases with increasing age.”
ResultLamberti, P., Zoccolella, S., Armenise, E., Lamberti, S. V., Fraddosio, A., Mari, M. D., Iliceto, G., & Livrea, P. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00973.x · Cited by 65
“…important and potentially reversible risk factor for systemic vascular diseases (as cardiac, 2005 EFNS European Journal of Neurology 12, 365–368 cerebral and peripheral vascular diseases) (Boushey et al., 1995; Haynes, 2002), cognitive impairment and dementia (Seshadri et al., 2002; Morris, 2003).”
BackgroundHomocysteine induces cell death of rat astrocytes in vitro
Maler, J. M., Seifert, W. E., Huether, G., Wiltfang, J., Rüther, E., Kornhuber, J., & Bleich, S. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00655-4 · Cited by 66
B-vitamins and prevention of dementia: Plenary Lecture
Clarke, R. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s0029665108006046 · Cited by 65
“Subsequently, several prospective studies have confirmed these findings((16,17)) but some studies have been unable to confirm such associations((18)).”
BackgroundResultFolate Deficiency Increases Postischemic Brain Injury
Endres, M., Ahmadi, M., Kruman, I. I., Biniszkiewicz, D., Meisel, A., & Gertz, K. R. (2004) · Stroke · doi:10.1161/01.str.0000153008.60517.ab · Cited by 69
Kim, J., Park, M. H., Kim, E., Han, C., Jo, S. A., & Jo, I. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.9.2093 · Cited by 64
“Longitudinal studies have proposed that elevated plasma homocysteine may be a risk factor for Alzheimer’s disease (10,11).”
BackgroundXu, W., Zhao, X., Lv, W. Y., Yang, H., Liu, S., Liang, H., Tu, Z., Xu, H., Qiao, W., Zhao, Q., et al. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300278 · Cited by 64
Miwa, K., Tanaka, M. R., Okazaki, S., Yagita, Y., Sakaguchi, M., Mochizuki, H., & Kitagawa, K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150458 · Cited by 72
“Therefore, it has been proposed that increased tHcy levels may be involved in predicting dementia [5].”
BackgroundChen, Z., Wang, Z., Chen, J., Wang, S., & Huang, X. (2012) · The Analyst · doi:10.1039/c2an35405e · Cited by 68
Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease
Kerkeni, M., Addad, F., Chauffert, M., Chuniaud, L., Miled, A., Trivin, F., & Maaroufi, K. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.05.010 · Cited by 66
Religa, D., Czyźewski, K., Styczyńska, M., Pepłońska, B., Lökk, J., Chodakowska-Żebrowska, M., Stepien, K., Winblad, B. G., & Barcikowska, M. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.05.040 · Cited by 65
Elevated cerebrospinal fluid and plasma homocysteine levels in ALS
Valentino, F., Bivona, G., Butera, D., Paladino, P., Fazzari, M., Piccoli, T., Ciaccio, M., & Bella, V. L. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02752.x · Cited by 75
“Other studies have found, however, that increased HC is associated decreased folate and vitamin B12 levels [12,26].”
BackgroundWang, H., Zhou, G., Mao, C., & Chen, X. (2012) · Dyes and Pigments · doi:10.1016/j.dyepig.2012.07.013 · Cited by 64
Leesutthiphonchai, W., Dungchai, W., Siangproh, W., Ngamrojnavanich, N., & Chailapakul, O. (2011) · Talanta · doi:10.1016/j.talanta.2011.04.041 · Cited by 64
Shea, T. B., & Rogers, E. J. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00412-6 · Cited by 67
Petronijević, N., Radonjić, N. V., Ivković, M., Marinković, D., Piperski, V., Duricić, B., & Paunović, V. R. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.09.009 · Cited by 64
“Increased total plasma Hcy levels have also been reported in several neuropsychiatric disorders including Alzheimer's disease (Seshadri et al., 2002), Parkinson's disease (O'Suilleabhain et al., 2006; Hassin-Baer et al., 2006; Todorović et al., 2006), depression (Bottiglieri et al., 2000; Folstein…”
BackgroundChen, X., Yang, Y. J., & Ding, M. (2005) · Analytica Chimica Acta · doi:10.1016/j.aca.2005.10.016 · Cited by 64
Rational design of fluorescent probe for Cys dynamics imaging in living cell
Xie, X., Yin, C., Yue, Y., & Huo, F. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.04.030 · Cited by 63
The road to precision medicine: Eliminating the “One Size Fits All” approach in Alzheimer’s disease
Behl, T., Kaur, I., Sehgal, A., Singh, S., Albarrati, A., Albratty, M., Najmi, A., Meraya, A. M., & BUNGAU, S. G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113337 · Cited by 71
Poddar, R., & Paul, S. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12102 · Cited by 72
“Hyperhomocysteinemia, a common metabolic disorder of the methionine cycle, is an independent risk factor for multiple neurodegenerative disorders such as cerebral stroke, ageassociated dementia, Alzheimer’s disease, Parkinson’s disease, cerebral atrophy, and seizures (Sacco et al. 1998; Miller 1999; Seshadri et al. 20…”
BackgroundMajtán, T., Singh, L. R., Wang, L., Kruger, W. D., & Kraus, J. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805928200 · Cited by 67
Atherosclerosis in epilepsy: Its causes and implications
Hamed, S. A. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.07.003 · Cited by 69
“prospective investigations have confirmed that HHcy [58,59], hyper-”
BackgroundHuang, H. S., Shi, F., Li, Y., Niu, L., Gao, Y. L., Shah, S. M., & Su, X. (2013) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2013.01.003 · Cited by 63
Kamdar, K. Y., Krull, K. R., El‐Zein, R. A., Brouwers, P. Y., Potter, B. S., Harris, L. L., Holm, S. E., Dreyer, Z. E., Scaglia, F., Etzel, C. J., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23162 · Cited by 63
“Other neurodegenerative disorders, including severe MTHFR deficiency, idiopathic cerebral folate deficiency, and a few cases of Rett syndrome have also been associated with low 5-MTHF levels or elevated homocysteine levels in the CSF [11, 19-23].”
BackgroundShen, C., Tseng, W., & Hsieh, M. (2008) · Journal of Chromatography A · doi:10.1016/j.chroma.2008.11.044 · Cited by 63
Ataie, A., Sabetkasaei, M., Haghparast, A., Moghaddam, A. H., Ataee, R., & Moghaddam, S. N. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2009.1278 · Cited by 63
“An elevated plasma level of Hcy (more than 14mM) is termed hyperhomocysteinemia.(4) Hcy is recognized as an independent risk factor for myocardial infarctions, coronary artery diseases, strokes, genetic disorders, Alzheimer’s diseases, and cognitive impairment.”
Accurate assessment and identification of naturally occurring cellular cobalamins
Hannibal, L., Axhemi, A. A., Glushchenko, A. V., Bahnson, E. M., Brasch, N. E., & Jacobsen, D. W. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.356 · Cited by 62
A colorimetric and near-infrared fluorescent probe for biothiols and its application in living cells
Yu, D., Zhang, Q., Ding, S., & Feng, G. (2014) · RSC Advances · doi:10.1039/c4ra06596d · Cited by 63
Rabaneda, L. G., Carrasco, M., López-Toledano, M. A., Murillo‐Carretero, M., Ruiz, F. A., Estrada, C., & Castro, C. (2008) · The FASEB Journal · doi:10.1096/fj.08-109306 · Cited by 69
“Hcy-treated mice showed levels of tHcy slightly higher than that reported for a heterozygous MTHFR ) mice model of moderate hyperhomocysteinemia (42), and higher than that found in patients with dementia and Alzheimer’s disease ( 14 M) (1, 43, 44).”
BackgroundResultMarco, P. D., Merello, E., Calevo, M. G., Mascelli, S., Pastorino, D., Crocetti, L., Biasio, P. D., Piatelli, G., Cama, A., & Capra, V. (2011) · Child s Nervous System · doi:10.1007/s00381-010-1372-y · Cited by 78
“Moderately elevated homocysteine levels have been correlated with an increased risk for multifactorial diseases, including NTDs [26, 40, 45, 46].”
BackgroundFolate and brain function in the elderly
D’Anci, K. E., & Rosenberg, I. H. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200411000-00011 · Cited by 64
Self-citationHomocysteine, B vitamins, and cognitive deficit in the elderly
Smith, A. D. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.5.785 · Cited by 63
Targeted Metabolomic Analysis in Alzheimer’s Disease Plasma and Brain Tissue in Non-Hispanic Whites
Kalecký, K., German, D. C., Montillo, A. A., & Bottiglieri, T. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-215448 · Cited by 62
“Betaine regulates signaling pathways involved in oxidative stress and inflammation [47] and facilitates re-methylation of homocysteine, linked to atherosclerosis [48] and AD [49].”
BackgroundChen, S., Hou, P., Zhou, B., Song, X., Wu, J., Zhang, H., & Foley, J. W. (2013) · RSC Advances · doi:10.1039/c3ra41554f · Cited by 62
Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease
Cardoso, B., Cominetti, & Cozzolino (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s27983 · Cited by 62
“age, gender, apolipoprotein E (ApoE) genotype and serum folate, vitamin B6, and vitamin B12 concentrations.(98)”
Culley, D. J., Raghavan, S. V., Waly, M. I., Baxter, M. G., Yukhananov, R. Y., Deth, R. C., & Crosby, G. J. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000266491.53318.20 · Cited by 65
“Epidemiologic studies have shown that mild to moderate chronic hyperhomocysteinemia is a risk factor for vascular and neurodegenerative disease, including dementia (3,4,30), and human studies indicate that plasma homocysteine remains elevated for 24 h or more after anesthesia using nitrous oxide (25).”
BackgroundBarnabé, A., Aléssio, A. C. M., Bittar, L. F., Mazetto, B. D. M., Bicudo, A. M., Paula, E. V. D., Höehr, N. F., & Annichino‐Bizzacchi, J. M. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0006-3 · Cited by 73
“Although almost all of these individuals in our study showed no anemia (data not shown), it should be emphasized that symptoms such as depression, dementia and impaired cognitive function, which have been associated with vitamin B12 deficiency, may be misinterpreted as aging-related co-morbidities rather than vitamin…”
BackgroundBlancquaert, D., Storozhenko, S., Daele, J. V., Stove, C. P., Visser, R. G. F., Lambert, W. E., & Straeten, D. V. D. (2013) · Journal of Experimental Botany · doi:10.1093/jxb/ert224 · Cited by 72
Troesch, B., Weber, P., & Mohajeri, M. H. (2016) · Nutrients · doi:10.3390/nu8120803 · Cited by 64
“initially dementia-free elderly for a median of eight years found that plasma Hcy level >14 μmol/L at baseline doubled the risk of developing AD [33].”
BackgroundMorris, J. C. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000167923.56275.d8 · Cited by 61
Cerebral Vascular Dysfunction in Methionine Synthase–Deficient Mice
Dayal, S., Devlin, A. M., McCaw, R. B., Liu, M., Arning, E., Bottiglieri, T., Shane, B., Faraci, F. M., & Lentz, S. R. (2005) · Circulation · doi:10.1161/circulationaha.104.529248 · Cited by 64
Upadhya, S. C., & Hegde, A. N. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00092-6 · Cited by 68
Ji, X., Wang, N., Zhang, J., Xu, S., Si, Y., & Zhao, W. (2020) · Dyes and Pigments · doi:10.1016/j.dyepig.2020.109089 · Cited by 63
Hyperhomocysteinemia in levodopa‐treated patients with Parkinson's disease dementia
Zoccolella, S., Dell’Aquila, C., Abruzzese, G., Antonini, A., Bonuccelli, U., Canesi, M., Cristina, S., Marchese, R., Pacchetti, C., Zagaglia, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22511 · Cited by 65
“Hcy levels greater than 14 lmol/L have been associated with a doubled risk of Alzheimer’s Disease (AD).(8)”
BackgroundKivipelto, M., Annerbo, S., Hultdin, J., Bäckman, L., Viitanen, M., Fratiglioni, L., & Lökk, J. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02590.x · Cited by 61
“In the Framingham study, comprising 111 demented subjects (83 with AD), the risk of AD was nearly doubled amongst subjects with high tHcy levels (>14 lM/l) [22].”
BackgroundA selective fluorescent probe for thiols based on α,β-unsaturated acyl sulfonamide
Zhang, H., WANG, P. H., Yang, Y., & Sun, H. (2012) · Chemical Communications · doi:10.1039/c2cc35513b · Cited by 61
The Effects of Acute Exercise and Exercise Training on Plasma Homocysteine: A Meta-Analysis
Deminice, R., Ribeiro, D. F., & Frajácomo, F. T. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151653 · Cited by 74
Therapeutic importance of hydrogen sulfide in age-associated neurodegenerative diseases
Jeong, N., Jung, J., & Tabassum, R. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266911 · Cited by 63
“H2S reduces the neurotoxicity of homocysteine by acting as a synaptic modulator (Seshadri et al., 2002).”
BackgroundStrålsjö, L., Witthöft, C. M., Sjöholm, I. M., & Jägerstad, M. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf020699n · Cited by 61
Schwammenthal, Y., & Tanné, D. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00826-9 · Cited by 70
Tuite, N. L., Fraser, K. R., & O'Byrne, C. P. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.13.4362-4371.2005 · Cited by 66
“Elevated serum levels of Hcy are associated with several serious diseases, including cardiovascular disease (1, 34), birth defects, and pregnancy complications (32, 33), as well as neurodegenerative diseases such as Alzheimer’s disease (26).”
BackgroundHou, X., Guo, X., Chen, B., Liu, C., Gao, F., Zhao, J., & Wang, J. (2014) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2014.12.009 · Cited by 61
Homocysteine, Cognitive Functions, and Degenerative Dementias: State of the Art
Luzzi, S., Cherubini, V., Falsetti, L., Viticchi, G., Silvestrini, M., & Toraldo, A. (2022) · Biomedicines · doi:10.3390/biomedicines10112741 · Cited by 71
Tacconi, E., Palma, G., Biase, D. D., Luciano, A., Barbieri, M., de Nigris, F., & Bruzzese, F. (2023) · Nutrients · doi:10.3390/nu15030563 · Cited by 66
Vitamin B12 and folate depletion in cognition: a review.
Moretti, R., Torre, P., Antonello, R. M., Cattaruzza, T., Cazzato, G., & Bava, A. (2004) · PubMed · Cited by 60
Impaired spatial memory in APP-overexpressing mice on a homocysteinemia-inducing diet
Bernardo, A., McCord, M. C., Troen, A. M., Allison, J. D., & McDonald, M. P. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.035 · Cited by 61
Homocysteine levels and amyotrophic lateral sclerosis: A possible link
Zoccolella, S., Bendotti, C., Beghi, E., & Logroscino, G. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960902919360 · Cited by 64
“However, increased plasma Hcy levels have been reported in patients with AD (5,6), mild cognitive impairment (MCI) (7,8) and PD (9), and now in ALS (27).”
BackgroundFan, J., Chen, C., Lin, Q. R., & Fu, N. (2012) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2012.08.004 · Cited by 60
Serum homocysteine levels in relation to clinical progression in multiple sclerosis
Teunissen, C. E., Killestein, J., Kragt, J. J., Polman, C. H., Dijkstra, C. D., & Blom, H. J. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.151555 · Cited by 68
“Plasma homocysteine concentrations in the highest quartile have been shown to double the risk of Alzheimer’s disease compared with the lowest quartile.(7) Interestingly, modulation of homocysteine levels can improve cognitive performance, as recently observed in a randomised, double blind, placebo controlled study on…”
BackgroundHomocysteine in Microvascular Endothelial Cell Barrier Permeability
Tyagi, S. C., Lominadze, D. G., & Roberts, A. M. (2005) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:43:1:037 · Cited by 65
“Although increased plasma Hcy levels are associated with vascular dementias and seizures (54,56,57), it is unclear whether MMP-induced Hcy-mediated vascular dementia is ameliorated by the GABAA receptor.”
BackgroundImmunohistochemical detection of N-homocysteinylated proteins in humans and mice
Perła‐Kaján, J., Stanger, O., Łuczak, M. W., Ziółkowska, A., Malendowicz, L. K., Twardowski, T., Lhoták, Š., Austin, R. C., & Jakubowski, H. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.04.001 · Cited by 58
More than the sum of its parts? Nutrition in Alzheimer's disease
Arnim, C. A. F. V., Gola, U., & Biesalski, H. K. (2010) · Nutrition · doi:10.1016/j.nut.2009.11.009 · Cited by 75
“plasma tHcy level greater than 14 mmol/L [74]”
BackgroundPaternain, L., Martišová, E., Campión, J., Martínez, J. A., Ramírez, M. J., & Milagro, F. I. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.11.031 · Cited by 67
“Moreover, high levels of homocysteine, an intermediate in the methionine metabolic pathway, have been described as one of the causal factors for dementia, cognitive impairment [26,27] and Alzheimer’s disease [28].”
BackgroundWang, J., Liu, Y., Jiang, M. H., Li, Y., Xia, L., & Wu, P. (2018) · Chemical Communications · doi:10.1039/c7cc08414e · Cited by 63
Solfrizzi, V., Colacicco, A. M., D'Introno, A., Capurso, C., Parigi, A. D., Capurso, S. A., Torres, F., Capurso, A., & Panza, F. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-102-314 · Cited by 60
“Therefore, an increased plasma homocysteine level seems to be a strong, independent risk factor for the development of dementia and AD, suggesting that the elevated homocysteine levels precede the onset of dementia, not resulting from dementia-relatednutritional and vitamin deficiencies [260].”
Michaelidou, A.-M., & Steijns, J. M. (2006) · International Dairy Journal · doi:10.1016/j.idairyj.2006.06.018 · Cited by 75
Biomarkers in the Diagnosis of Alzheimer’s Disease: Are We Ready?
Sunderland, T., Hampel, H. J., Takeda, M., Putnam, K. T., & Cohen, R. M. (2006) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706291088 · Cited by 70
“These purported biomarkers have ranged from an ophthalmologic sensitivity test to genetic markers to cerebrospinal fluid (CSF) peptide measures of amyloid and tau to urinary measures of brain peptides and a multitude of neuroimaging parameters, and the list continues to grow steadily (Table 2).(13-22) Some potential d…”
BackgroundGiusti, B. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.08.020 · Cited by 60
Zhao, C., Li, X., & Wang, F. (2014) · Chemistry - An Asian Journal · doi:10.1002/asia.201402043 · Cited by 59
Wen, X., Zhao, X., Peng, B.-F., Yuan, K., Li, X., Zhu, L., & Lü, H.-L. (2021) · Applied Surface Science · doi:10.1016/j.apsusc.2021.149735 · Cited by 59
Click chemistry in the design of AIEgens for biosensing and bioimaging
Giel, M., & Hong, Y. (2023) · Aggregate · doi:10.1002/agt2.336 · Cited by 61
Sun, Q., He, D., Zhang, L., Li, Z., Qu, L., & Sun, Y. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117272 · Cited by 63
Homocysteine Metabolism and Cerebrospinal Fluid Markers for Alzheimer's Disease
Popp, J., Lewczuk, P., Linnebank, M., Cvetanovska, G., Smulders, Y. M., Kölsch, H., Frommann, I., Kornhuber, J., Maier, W., & Jessen, F. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1187 · Cited by 66
“Several epidemiologic studies have found hyperhomocysteinemia to be a strong and independent risk factor for the development of AD dementia [7,8].”
Wong, A., Mok, V., Fan, Y., Lam, W. W. M., Liang, K. S., & Wong, K. S. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0022-x · Cited by 59
“Excess amounts of homocysteine, a condition known as hyperhomocysteinemia, are associated with increased risk of cardiovascular disease [2], Alzheimer’s disease [3, 4] and cerebrovascular disease [5].”
BackgroundResultBeneficial Effects of Folic Acid on Enhancement of Memory and Antioxidant Status in Aged Rat Brain
Singh, R., Kanwar, S. S., Sood, P. K., & Nehru, B. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9557-1 · Cited by 63
“These results are further supported by ( Semsci et al. 1991; Navarro and Boveris 2004).”
ResultWang, J., Li, R., Xiaohuan, L., & Li, Z. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.06.157 · Cited by 59
Wang, Y. N., Zhu, M., Jiang, E., Hua, R., Na, R., & Li, Q. X. (2017) · Scientific Reports · doi:10.1038/s41598-017-03901-8 · Cited by 59
Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization
Shirafuji, N., Hamano, T., Yen, S.-H. C., Kanaan, N. M., Yoshida, H., Hayashi, K., Ikawa, M., Yamamura, O., Kuriyama, M., & Nakamoto, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030891 · Cited by 65
“Hyperhomocysteinemia (HHCy) also is considered an important risk factor for dementias, including AD [11] and vascular dementia [12].”
BackgroundA Highly Selective Fluorescent Probe for Thiophenols
Jiang, W., Fu, Q., Fan, H., Ho, J., & Wang, W. (2007) · Angewandte Chemie · doi:10.1002/ange.200702271 · Cited by 61
Seripa, D., Forno, G. D., Matera, M. G., Gravina, C., Margaglione, M., Palermo, M., Wekstein, D., Antuono, P., Davis, D., Daniele, A., et al. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00040-x · Cited by 61
“[45] found an increased plasma homocysteine level, a strong risk factor for AD.”
BackgroundVascular risk and genetics of sporadic late-onset Alzheimer’s disease
Panza, F., D’Introno, A., Colacicco, A. M., Basile, A. M., Capurso, C. A., Kehoe, P. G., Capurso, C. A., & Solfrizzi, V. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0071-1 · Cited by 67
“Thus increased homocysteine plasma levels seem to be a strong, independent risk factor for the development of dementia and AD, suggesting that the elevated homocysteine levels precede the onset of dementia and do not result from dementia-related nutritional and vitamin deficiencies (Seshadri et al., 2002; Solfrizzi et…”
BackgroundFeng, L., Isaac, V., Sim, S. K. Y., Ng, T. P., Krishnan, K. R., & Chee, M. W. L. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.10.017 · Cited by 66
Serum C-Reactive Protein and Cognitive Function in Healthy Elderly Italian Community Dwellers
Ravaglia, G., Forti, P., Maioli, F., Brunetti, N., Martelli, M., Servadei, L., Bastagli, L., Bianchin, M., & Mariani, E. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.8.1017 · Cited by 59
“Several lines of evidence support the view that, because of its proinflammatory (29), prothrombotic (23), and neurotoxic effects (30,31), homocysteine may be an important risk factor for both AD and vascular dementia (32).”
BackgroundTchantchou, F., Graves, M. V., Ortiz, D., Chan, A., Rogers, E., & Shea, T. B. (2006) · PubMed · Cited by 65
Targeting DNA Methylation in the Adult Brain through Diet
Allison, J., Kaliszewska, A., Uceda, S., Reiriz, M., & Arias, N. (2021) · Nutrients · doi:10.3390/nu13113979 · Cited by 67
“Thus, several studies have also linked Hcy to dementia, [180], depressive phenotypes [181] and Parkinson’s disease [182,183].”
BackgroundNutritional status determinants and cognition in the elderly
Donini, L. M., Felice, M. R. D., & CANNELLA, C. (2007) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2007.01.022 · Cited by 67
Linnebank, M., Lutz, H. H., Jarre, E., Vielhaber, S., Noelker, C., Struys, E. A., Jakobs, C., Klockgether, T., Evert, B. O., Kunz, W. S., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.010 · Cited by 62
“…has evolved as a risk factor for cardio- and cerebrovascular diseases, but also for various neurodegenerative disorders such as Alzheimer’s disease (AD), cognitive dysfunction and brain atrophy in the elderly (Mudd et al., 2001; Prins et al., 2002; Sachdev et al., 2002; Seshadri et al., 2002).”
BackgroundHydrogen sulfide antagonizes homocysteine-induced neurotoxicity in PC12 cells
Tang, X., Shen, X., Huang, Y.-E., Ren, Y., Chen, R., Hu, B., He, J., Yin, W., Xu, J., & Jiang, Z.-S. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.07.2039 · Cited by 61
Durga, J., VANBOXTEL, M., Schouten, E. G., Bots, M. L., Kok, F. J., & Verhoef, P. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.003 · Cited by 64
Undiagnosed Diseases in Patients with Dementia – A Potential Target Group for Intervention
Löppönen, M. K., Isoaho, R. E., Räihä, I. J., Vahlberg, T. J., Loikas, S. M., Takala, T. I., Puolijoki, H., Irjala, K. M., & Kivelä, S.-L. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000080126 · Cited by 58
Bosco, P. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.025866 · Cited by 58
Bowman, G. L., Shannon, J., Ho, E., Traber, M. G., Frei, B. B., Oken, B., Kaye, J. A., & Quinn, J. F. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181f333d6 · Cited by 65
Polymer Dots for Photoelectrochemical Bioanalysis
Li, Y., Zhang, N., Zhao, W., Jiang, D., Xu, J., & Chen, H. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00162 · Cited by 58
Li, X., Ma, H., Qian, J., Cao, T., Teng, Z., Iqbal, K., Qin, W., & Guo, H. (2018) · Talanta · doi:10.1016/j.talanta.2018.10.095 · Cited by 58
Homocysteine in neuropsychiatric disorders of the elderly
Reutens, S. G., & Sachdev, P. S. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.723 · Cited by 67
Dietary Pattern Is Associated with Homocysteine and B Vitamin Status in an Urban Chinese Population
Gao, X., Yao, M., McCrory, M. A., Roberts, S. B., Tucker, K. L., Ma, G., & Li, Y. (2003) · Journal of Nutrition · doi:10.1093/jn/133.11.3636 · Cited by 65
Metadata
- Authors
- Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A.
- Affiliations
- Boston University (US)
- Tufts University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-02-14
- Volume
- 346
- Issue
- 7
- Pages
- 476-483
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2052588755
- Cited by
- 3,237
- References
- 55
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 82 · 2023: 79 · 2022: 90 · 2021: 102 · 2020: 91 · 2019: 133 · 2018: 132 · 2017: 138 · 2016: 138 · 2015: 149 · 2014: 174 · 2013: 154 · 2012: 155
- FWCI
- 111.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc038038-022)
- National Institute on Aging (5R01 AG 08122-11, 5R01-AG16495-02, R01AG016495, R01AG008122)
- National Heart, Lung, and Blood Institute (N01-HC-38038)
- National Institute of Neurological Disorders and Stroke (5R01 NS 17950-19, R01NS017950)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- plasma homocysteine, dementia, Alzheimer's disease, risk factors, newly diagnosed dementia, folic acid, vitamin B12, vitamin B6, apolipoprotein E, Framingham Heart Study, cognitive decline
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Dementia, Female, Homocysteine, Humans, Male, Risk Factors, Cohort Studies, Confounding Factors, Epidemiologic, Multivariate Analysis, Proportional Hazards Models, Hyperhomocysteinemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.